RESISTANCE TO IMMUNOTHERAPY

Clinical trials for RESISTANCE TO IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new RESISTANCE TO IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for RESISTANCE TO IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for liver cancer patients when first immunotherapy fails

Disease control Not yet recruiting

This study is testing a new three-drug combination for people with advanced liver cancer that initially responded to immunotherapy but has since started growing again. It aims to see if adding a new drug (Ivarmacitinib) to two existing ones can help control the cancer. The trial …

Matched conditions: RESISTANCE TO IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

RESISTANCE TO IMMUNOTHERAPY

Get alerted when new RESISTANCE TO IMMUNOTHERAPY trials appear

New hope for liver cancer patients when first immunotherapy fails